Furthermore, our findings revealed that NPC patients with high FLI1-TIE1 levels were related to poor prognosis, suggesting that targeting FLI1/TIE1 could be a potential therapeutic strategy to enhance the efficacy of NPC radiotherapy in the future. Here, TIE1 is linked to nasopharyngeal carcinoma.